Investor Resources

MMED (NEO)

MNMD (NASDAQ)

mesh background
press releases Downloads Financials Corporate Governance

Press Release

MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT

7/28/2021 corner arrow

Press Release

MindMed Chosen to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit

7/12/2021 corner arrow

Press Release

MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

7/8/2021 corner arrow
View all

Financials

document icon icon arrow down
PDF

Year-end 2020 Management's Discussion and Analysis
document icon icon arrow down
PDF

2020 Audited Annual Consolidated Financial Statements
document icon icon arrow down
PDF

Third Quarter 2020 Management's Discussion and Analysis
document icon icon arrow down
PDF

Third Quarter 2020 Consolidated Financial Statements
document icon icon arrow down
PDF

Second Quarter 2020 Consolidated Financial Statements
document icon icon arrow down
PDF

Second Quarter 2020 Management's Discussion and Analysis
webinar icon icon arrow down
WEBINAR

Q2 2020 Earnings Call Recording
document icon icon arrow down
PDF

2019 Audited Annual Consolidated Financial Statements
document icon icon arrow down
PDF

Year-end 2019 Management's Discussion and Analysis
podcast icon icon arrow down
PODCAST

2019 Year End Earnings Call & Corporate Update
document icon icon arrow down
PDF

First Quarter 2021 Management's Discussion and Analysis
document icon icon arrow down
PDF

First Quarter 2021 Consolidated Financial Statements
MIndMed booklet